Biology and management of acquired severe aplastic anemia

Current Opinion in Oncology

Volumn 10, Issue 2, 1998, Pages 95-99

  Brodsky, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MEBENDAZOLE; SULFONAMIDE; THIAZIDE DIURETIC AGENT; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; DRUG INDUCED DISEASE; ENVIRONMENTAL EXPOSURE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; VIRUS INFECTION;

EID: 0031951064     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199803000-00002     Document Type: Review

References (44)

1. Ehrlich P: Ueber einem fall von anamie mit bemer-kungen uber regenerative veranderungen des knochenmarks. Charite-Annalen 1888, 13:301-309.
2. Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979, 53:504-514.
3. Thomas ED, Storb R, Fefer A, Slichter SJ, Bryant JI, Buckner CD, Neiman PE, Clift RA, Funk DD, Lerner KE: Aplastic anaemia treated by marrow transplantation. Lancet 1972, i:284-289.
4. Mathe G, Amiel JL, Schwarzenberg L, Choay J, Trolard P, Schneider M, Hayat M, Schlumberger JR, Jasmin C: Bone marrow graft in man after conditioning by antilymphocytic serum. BMJ 1970, 2:131-136.
5. Speck B, Gluckman E, Haak HL, van Rood JJ: Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 1977, iv:1145-1148.
6. Champlin R, Ho W, Gale RP: Antithymocyte globulin treatment in patients with aplastic anemia. N Engl J Med 1983, 308:113-118.
7. Brodsky RA, Sensenbrenner LL, Jones RJ: Complete remission in acquired severe aplastic anemia following high-dose cyclophosphamide. Blood 1996, 87:491-494.
8. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T, Sirijirachai J, Piankijagum A, Porapakkham Y, Vannasaeng S, Leaverton PE, et al.: Low drug attributability of aplastic anemia in Thailand. Blood 1997, 89:4034-4039. Large population-based case-control study of aplastic anemia in Thailand, demonstrates that drugs are uncommon causes of aplastic anemia and their use does not explain the relatively high incidence of aplastic anemia in Thailand.
9. Hagler L, Pastore RA, Bergin JJ, Wrensch MR: Aplastic anemia following viral hepatitis: report of two fatal cases and literature review. Medicine 1975, 54:139-164.
10. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS: Hepatitis-associated aplastic anemia. N Engl J Med 1997, 336:1059-1064. Demonstration of the role of hepatitis viruses in the etiology of aplastic anemia.
11. Tzakis AG, Arditi M, Whittington PF, Yanaga K, Esquivel C, Andrews WA,. Makowka L, Malatak J, Freese DK, Stock PG, et al.: Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. N Engl J Med 1988, 319:393-396.
12. Cattral MS, Langnas AN, Markin RS, Antonson DL, Heffron TG, Fox IJ, Sorrell MF, Shaw BW Jr: Aplastic anemia after liver transplantation for fulminant liver failure. Hepatology 1994, 20:813-818.
13. Brown KE, Wong S, Young NS: Prevalence of GBV-C/Hgv, a novel "hepatitis" virus, in patients with aplastic anaemia. Br J Haematol 1997, 97:492-496.
14. Young NS, Maciejewsi J: The pathology of acquired aplastic anemia. N Engl J Med 1997, 336:1365-1372. Outstanding review of the pathophysiology of SAA.
15. Nakao S, Takami A, Takamatsu H, Zeng W, Sugimori N, Yamazaki H, Miura Y, Ueda M, Shiobara S, Yoshioka T, et al.: Isolation of a T-cell clone showing HLA-DRBI*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia. Blood 1997, 89:3691-3699. Direct demonstration of cytotoxic T-cell attack occurring in an HLA-DRB1*0405 restricted manner in a patient with SAA.
16. Socie G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Veer-Korthof EV, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 1993, 329:1152-1157.
17. Nagarajan S, Brodsky R, Young NS, Medof WE: Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood 1995, 86:4656-4661.
18. de Planque MM, Bacigalupo A, Wursch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C: Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Br J Haematol 1989, 73:121-126.
19. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B: Late haematological complications in severe aplastic anaemia. Br J Haematol 1988, 69:413-418.
20. Moore MAS, Castro-Malaspina H: Immunosuppression in aplastic anemia-postponing the inevitable? N Engl J Med 1991, 324:1358-1360.
21. Rosse WF: Paroxysmal nocturnal hemoglobinuria as a molecular disease. Medicine 1997, 76:63-93. Outstanding review of the molecular and cell biology of PNH.
22. Brodsky RA, Vala MS, Barber JP, Medof ME, Jones RJ: Resistance to apoptosis caused by PIG-A gene mutations in paroxymal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A 1997, 94:8756-8760. Demonstrates that PIGA gene mutations block apoptosis.
23. Horikawa K, Nakakuma H, Kawaguchi T, Iwamoto N, Nagakura S, Kagimoto T, Takatsuki K: Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood 1997, 90:2716-2722.
24. Ohara A, Kojima S, Hamajima N, Tsuchida M, Imashuku S, Ohta S, Sasaki H, Okamura J, Sugita K, Kigasawa H, et al.: Myelodysplastic syndrome and acute myelogenous leukemia as a late clonal complication in children with acquired aplastic anemia. Blood 1997, 90:1009-1013. Large study detailing the high risk of developing MDS in SAA patients treated with immunosuppressive therapy.
25. Thomas ED, Storb R: Acquired severe aplastic anemia: progress and perplexity. Blood 1984, 64:325-328.
26. Passweg JR, Socie G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, et al.: Bone marrow transplantation for severe aplastic anemia: has outcome improved? Blood 1997, 90:858-864. Registry data demonstrating improved outcome for SAA patients treated with BMT over the past two decades.
27. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg JH, Doney K, et al.: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 1994, 84:941-949.
28. May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Jones RJ, Miller CB, Mellits ED, Vogelsang GB, Wagner J, et al.: BMT for severe aplastic anemia using cyclosporin. Bone Marrow Transplant 1993, 11:459-464.
29. Storb R, Leisenring W, Anasetti C, Appelbaum FR, Buckner CD, Bensinger WI, Chauncey T, Clift RA, Deeg HJ, Doney KC, et al.: Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by Cyclophosphamide combined with antithymocyte globulin. Blood 1997, 89:3890-3891.
30. Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, et al.: Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Bone Marrow Transplant 1997, 19:1085-1087.
31. Sobocinksi KA, Horowitz MM, Rowlings PA, Zhang M, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM: Bone marrow transplantation-1994: a report form the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J Hematother 1994, 3:95-102.
32. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K, Kupst MJ, French J 3rd, Truitt R, Lawton C, et al.: Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996, 94:65-72.
33. Davies SM, Wagner JE, Defor T, Blazar BR, Katsanis E, Kersey JH, Orchard PJ, McGlave PB, Weisdorf DJ, Ramsay NKC: Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia. Br J Haematol 1997, 96:749-756.
34. Henslee-Downey PJ, Abhyankar SH, Parrish RS, Pati AR, Godder KT, Neglia WJ, Goon-Johnson KS, Geier SS, Lee CG, Gee AP: Use of partially mismatched related donors extends access to allogeneic marrow transplant. Blood 1997, 89:3864-3872.
35. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte J, et al.: Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 1997, 337:373-381.
36. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavacher A, Vogt HG, Hermann F, Freund M, Meusers P, Salama A, Heimpel H: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991, 324:1297-1304.
37. Rosenfeld SJ, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporin as treatment for severe aplastic anemia. Blood 1995, 85:3058-3065.
38. Young NS: Autoimmunity and its treatment in aplastic anemia. Ann Intern Med 1997, 126:166-168.
39. Doney K, Leisenring W, Storb R, Appelbaum FR: Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med 1997, 126:107-115. Retrospective single-center analysis comparing survival rates and long-term complications following BMT or immunosuppressive therapy in SAA patients.
40. Jones RJ, Collector ML, Barber JP. Vala MS, Fackler MJ, May WS, Griffin CA, Hawkins AL, Zehnbauer BA, Hilton J, et al.: Characterization of mouse lymphohematopoietic stem cells lacking colony-forming activity. Blood 1996, 88:487-491.
41. Sensenbrenner LL, Steele AA, Santos GW: Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia. Exp Hematol 1977, 5:51-58
42. Speck B, Cornu P, Jeannet M, Nissen C, Burri HP, Groff P, Nagel GA, Buckner CD: Autologous marrow recovery following allogeneic marrow transplantation in a patient with severe aplastic anemia. Exp Hematol 1976, 4:131-137.
43. Socie G, Landman J, Gluckman E, Devergie A, Raynal B, Esperou-Bourdeau H, Brison O: Short-term study of chimaerism after bone marrow transplantation for severe aplastic anaemia. Br J Haematol 1992, 80:391-398.
44. Thomas ED, Storb R, Giblett ER, Longpre B, Weiden PL, Fefer A, Witherspoon R, Clift RA, Buckner CD: Recovery from aplastic anemia following attempted marrow transplantation. Exp Hematol 1976, 4:97-102.